XOMA (XOMA) Misses Q2 EPS by 7c

XOMA (NASDAQ: XOMA) reported Q2 EPS of ($0.59), $0.07 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on XOMA (XOMA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c